Latka logo

Celonis vs MyDoctorCalls: Revenue, Funding & Team Size Compared

Celonis generates $771M in revenue; MyDoctorCalls has not disclosed its revenue. The table below compares Celonis and MyDoctorCalls on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.

Celonis vs MyDoctorCalls compared on revenue, funding, valuation, customers and team size
CompanyCelonis logoCelonisThis companyMyDoctorCalls logoMyDoctorCalls
Revenue$771MNot disclosed
Valuation$13BNot disclosed
Funding raised$2.4BNot disclosed
Customers500Not disclosed
Team size3.7KNot disclosed
Cash flow$1Not disclosed
Founded20112011
HQMunich, GermanyUnited States

Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.

Celonis logo

Celonis at a glance

Celonis generates $771M in revenue with 3.7K employees, headquartered in Munich, Germany.

Revenue
$771M
Valuation
$13B
Funding
$2.4B
Customers
500
Team size
3.7K
Founded
2011

Celonis is a company based in Munich, Germany, that provides a process mining platform that uses artificial intelligence and machine learning to help businesses analyze, visualize, and optimize their processes. The company was founded in…

MyDoctorCalls logo

MyDoctorCalls at a glance

Founded
2011

Welcome to MyDoctorCalls. As you know, one of the most difficult challenges doctors face in today’s advertising world is tracking the performance of their advertisements. The list of places to advertise is endless (e.g. search engines…

Other Celonis alternatives

Celonis competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.

Celonis vs MyDoctorCalls: frequently asked questions

How much revenue does Celonis make?

Celonis generates $771M in annual revenue with a team of 3.7K.

How much funding has Celonis raised?

Celonis has raised $2.4B in total funding since it was founded in 2011.